Endocrinology (all articles)
Association of Dairy Consumption with Metabolic Syndrome, Hypertension and Diabetes in 147 812 Individuals from 21 Countries
2 Jun, 2020 | 04:52h | UTCCommentary: Study shows dairy products are linked to lower risks of diabetes and high blood pressure – News Medical
Systematic Review: The Effects from Screening for Type 2 Diabetes are Uncertain
1 Jun, 2020 | 03:47h | UTCScreening for type 2 diabetes mellitus – Cochrane Library
Summary: Screening for type 2 diabetes mellitus – Cochrane Library
[Abstract Only] Study: Primary Aldosteronism Common and Largely Unrecognized in Patients with Hypertension
1 Jun, 2020 | 03:41h | UTCThe Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study – Annals of Internal Medicine (link to abstract – $ for full-text)
International Consensus on the Diagnosis and Management of Dumping Syndrome
29 May, 2020 | 03:12h | UTC
Short Review: Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020
27 May, 2020 | 02:18h | UTCUsing Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020 – JAMA (free for a limited period)
Study: Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients
26 May, 2020 | 09:43h | UTC
Systematic Review Shows Evidence is Inconclusive on the Use of Non‐nutritive Sweeteners for Diabetes Mellitus
26 May, 2020 | 09:27h | UTCNon‐nutritive sweeteners for diabetes mellitus – Cochrane Library
Summary: Non-nutritive sweeteners for diabetes mellitus – Cochrane Library
Meta-Analysis: Progression to Type 2 Diabetes in Women with Previous Gestational Diabetes
14 May, 2020 | 02:11h | UTCCommentary: Gestational diabetes—missed opportunities in post-partum follow-up – The BMJ Opinion
Comparison Approaches to Lipid Management: AHA/ACC vs. ESC/EAS Guidelines
12 May, 2020 | 03:07h | UTC
Cohort Study: SLGT2 Inhibitors Linked to Lower Risk of Renal Events in Patients with Type 2 Diabetes
7 May, 2020 | 08:57h | UTCEditorial: SGLT2 inhibitors and kidney outcomes in the real world
Commentary: Certain diabetes drugs may protect against serious kidney problems – The BMJ
Related Analysis: Communicating emerging risks of SGLT2 inhibitors—timeliness and transparency of medicine regulators – The BMJ
Obesity Could Shift Severe COVID-19 Disease to Younger Ages
5 May, 2020 | 04:53h | UTCObesity could shift severe COVID-19 disease to younger ages – The Lancet
NEW Correspondence—D Kass et al examined the correlation between BMI & age in 265 #COVID19 patients admitted to ICU at 6 hospitals & found a significant inverse correlation between age & BMI, in which younger individuals were more likely to be obese https://t.co/SrNSp2W7JQ pic.twitter.com/ozpBug5Mv9
— The Lancet (@TheLancet) May 1, 2020
[Abstract Only] Randomized Trial: No Benefit from L-thyroxine Among Elderly Patients with Symptomatic Subclinical Hypothyroidism
5 May, 2020 | 04:11h | UTCL-Thyroxine Therapy for Older Adults With Subclinical Hypothyroidism and Hypothyroid Symptoms: Secondary Analysis of a Randomized Trial – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries: L-thyroxine did not improve symptoms or tiredness in older patients with subclinical hypothyroidism – ACP Internist AND More Evidence Against L-Thyroxine for Subclinical Hypothyroidism – NEJM Journal Watch
Related Articles: Association Between Levothyroxine Treatment and Thyroid-Related Symptoms Among Adults Aged 80 Years and Older With Subclinical Hypothyroidism – JAMA AND Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism – New England Journal of Medicine
Obesity and Impaired Metabolic Health in Patients with COVID-19
26 Apr, 2020 | 21:25h | UTCObesity and impaired metabolic health in patients with COVID-19 – Nature Reviews Endocrinology
Practical Recommendations for the Management of Diabetes in Patients with COVID-19
26 Apr, 2020 | 21:24h | UTC
Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths
23 Apr, 2020 | 09:27h | UTCCommentaries: Salt substitution could prevent almost half a million deaths from CVD in China – George Institute for Global Health AND Embracing salt substitutes could help China prevent 450K CVD deaths per year – Cardiovascular Business
Endocrinology in the Time of COVID-19: Management of Adrenal Insufficiency
22 Apr, 2020 | 08:52h | UTC
Podcast: Hypothyroidism Master Class
21 Apr, 2020 | 07:56h | UTC
Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-income Countries
21 Apr, 2020 | 07:53h | UTC
Study: HDL-C is Associated with Mortality from All Causes, Cardiovascular Disease and Cancer in a J-shaped Dose-response Fashion
17 Apr, 2020 | 01:55h | UTC
AHA Statement: Management of Stable Coronary Artery Disease in Patients with Type 2 Diabetes
14 Apr, 2020 | 02:33h | UTCNews Release: People with type 2 diabetes and heart disease may benefit from newer therapies – American Heart Association
Studies: Obesity Increases the Risk of Complications in Patients with Covid-19
13 Apr, 2020 | 00:14h | UTC2 – Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission – Clinical Infectious Diseases AND Commentary: In New York, obesity appears to raise COVID-19 risk – CIDRAP
Studies: Diabetes Increases the Risk of Complications in Patients with Covid-19
13 Apr, 2020 | 00:12h | UTC1 – Prevalence and impact of diabetes among people infected with SARS-CoV-2 – Journal of Endocrinological Investigation AND Commentary: Diabetes Could Increase Severity of COVID-19, Including Risk of ICU Admission and Death – MedicalResearch.com
2 – Evidence Reviews: Diabetes and risks from COVID-19 – CEBM University of Oxford AND Managing diabetes during the COVID-19 pandemic – CEBM University of Oxford
Meta-Analysis: Comparative Weight Loss with Popular Diets
3 Apr, 2020 | 03:50h | UTCEditorial: Comparative weight loss with popular diets
[Abstract Only] A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity
1 Apr, 2020 | 05:39h | UTCA Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity – New England Journal of Medicine (link to abstract – $ for full-text)
#ACC20 – Randomized Trial: Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
30 Mar, 2020 | 01:03h | UTCSee also: Visual Abstract
Just Presented at the 2020 American College of Cardiology Virtual Meeting (free access)